Barely Significant
← all excerpts

An online gene expression assay for determining adjuvant therapy eligibility in patients with stage 2 or 3 colon cancer.

Br J Cancer · 2010 · PMC3008603 · PMID 21119668

Europe PMCDOI
1
hedged sentence
0.0570
closest p · 1.1× alpha
0.0570
boldest claim

The sentences

approaching significanceP =0.057so close (0.05 < p ≤ 0.1)
Kaplan–Meier analysis of risk groups stratified by gene expression risk group and clinical staging was then performed, resulting in a significant difference in DFS for stage 2 patients ( P =0.0031) and approaching significance for stage 3 patients ( P =0.057), as shown in Table 2 .

also in 2,640 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.